Evidence map›Paper›PMID 37151474›Full record

ArticleSurgical neurology international2023

Spinal mesenchymal chondrosarcoma: A case report of a rare malignant tumor.

Younes Dehneh, Mohannad Aldabbas, Mohammed Alamine Elfarissi, Mohamed Khoulali, Noureddine Oulali, Faycel Moufid

Open access · hybridAbstract readCase Reports
In one paragraph

Article in Surgical neurology international, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.7field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Younes DehnehDepartment of Neurosurgery, University Hospital Center Mohammed VI Oujda, Morocco.
Mohannad AldabbasDepartment of Neurosurgery, University Hospital Center Mohammed VI Oujda, Morocco.
Mohammed Alamine ElfarissiDepartment of Neurosurgery, University Hospital Center Mohammed VI Oujda, Morocco.
Mohamed KhoulaliDepartment of Neurosurgery, University Hospital Center Mohammed VI Oujda, Morocco.
Noureddine OulaliDepartment of Neurosurgery, University Hospital Center Mohammed VI Oujda, Morocco.
Faycel MoufidFaculty of Medicine and Pharmacy, Mohammed Premier Oujda, Morocco.
Mohamed I University · MAPremier University · BD

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Mesenchymal chondrosarcoma is an uncommon malignant variant of chondrosarcoma that mainly affects the bones and cartilaginous tissues, but may rarely involve the spine. Careful preoperative planning for surgical tumor removal and spine reconstruction is mandatory and must be based on oncologic and surgical staging. Case Description: Over 1 month, a 16-year-old female became paraplegic with a T9 sensory level and urinary dysfunction. The magnetic resonance imaging revealed an intraspinal extradural T7-T9 mass that was isointense in T1W1 and markedly enhanced with gadolinium. The patient underwent gross-total tumor resection followed by an osteoplastic laminectomy with fusion. The histological examination was consistent with a mesenchymal chondrosarcoma. She had received radiation and chemotherapy. One year later, she was readmitted for tumor recurrence with multiple metastases involving L1, the lung, and peritoneum. Despite full course of radiotherapy and chemotherapy, she died after 6 months of the second surgery. Conclusion: Total resection of mesenchymal chondrosarcomas is the gold standard for treatment and is typically followed by radiation and/or chemotherapy. However, the status of residual tumor, local extension, and or metastases best determine the overall survival which may prove extremely limited.

Indexed as

ChondrosarcomaMesenchymal chondrosarcomaMetastatic chondrosarcomaSpinal tumors

Identifiers

PMID37151474
PMCPMC10159291
OpenAlexW4362701040

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.